Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD3 Complex | 2 | 2025 | 86 | 1.130 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 327 | 0.770 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 542 | 0.630 |
Why?
|
| Gene Editing | 3 | 2025 | 187 | 0.580 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1198 | 0.470 |
Why?
|
| CRISPR-Cas Systems | 3 | 2025 | 253 | 0.410 |
Why?
|
| T-Lymphocytes | 5 | 2024 | 1706 | 0.310 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2023 | 60 | 0.270 |
Why?
|
| Plasma Cells | 1 | 2024 | 55 | 0.220 |
Why?
|
| Hydrogels | 1 | 2024 | 82 | 0.220 |
Why?
|
| Mice, Inbred NOD | 1 | 2024 | 285 | 0.220 |
Why?
|
| Adoptive Transfer | 1 | 2025 | 236 | 0.220 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2024 | 263 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2025 | 482 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2025 | 217 | 0.210 |
Why?
|
| Burkitt Lymphoma | 1 | 2023 | 144 | 0.190 |
Why?
|
| NF-kappa B | 1 | 2022 | 455 | 0.170 |
Why?
|
| Subcutaneous Fat | 1 | 2020 | 29 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 293 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 1269 | 0.150 |
Why?
|
| Housing | 1 | 2018 | 59 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 826 | 0.140 |
Why?
|
| Obesity | 2 | 2020 | 2262 | 0.140 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 90 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2019 | 395 | 0.140 |
Why?
|
| Inflammation | 2 | 2022 | 1431 | 0.130 |
Why?
|
| Weight Loss | 1 | 2020 | 482 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2020 | 637 | 0.120 |
Why?
|
| Mice | 4 | 2025 | 17630 | 0.120 |
Why?
|
| Animals | 5 | 2025 | 34072 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2022 | 4501 | 0.090 |
Why?
|
| Humans | 7 | 2025 | 124593 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 196 | 0.070 |
Why?
|
| HLA-A2 Antigen | 1 | 2025 | 25 | 0.060 |
Why?
|
| Sepharose | 1 | 2024 | 16 | 0.060 |
Why?
|
| Tissue Scaffolds | 1 | 2024 | 78 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2024 | 95 | 0.050 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2023 | 13 | 0.050 |
Why?
|
| Collagen | 1 | 2024 | 315 | 0.050 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2022 | 36 | 0.050 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2022 | 21 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2024 | 259 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2025 | 691 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2024 | 324 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 131 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 806 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 122 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2023 | 6135 | 0.040 |
Why?
|
| Genome | 1 | 2023 | 472 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3063 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2023 | 676 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2020 | 83 | 0.040 |
Why?
|
| Models, Biological | 1 | 2024 | 1459 | 0.040 |
Why?
|
| Housing, Animal | 1 | 2018 | 19 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2024 | 3038 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4350 | 0.040 |
Why?
|
| Antibodies | 1 | 2019 | 373 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 330 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2018 | 187 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2018 | 149 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 212 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 298 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2019 | 462 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1387 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 1290 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 1739 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4406 | 0.020 |
Why?
|
| Male | 2 | 2019 | 61191 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 19703 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 26714 | 0.010 |
Why?
|
| Female | 1 | 2020 | 66482 | 0.010 |
Why?
|